Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky WassilifiledCriticalNowicky Wassili
Publication of PT75226ApublicationCriticalpatent/PT75226A/en
Publication of PT75226BpublicationCriticalpatent/PT75226B/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Medicines Containing Plant Substances
(AREA)
Abstract
Treating a human patient having tumour cells located in the rectum, liver, pancras, stomach, skin, glands, lymphatic system, bone, parotid gland, ovaries, uterus, lungs, prostate, thyroid, abdomen or colon comprises administering a mixt. of non-toxic cytostatic alkaloid derivs. (I) in an amt. of 0.5-650 mg, where at least a portion of (I) is comprised of derivs. of chelilutin so as to at least retard the growth of the tumour cells. The alkaloid derivs. may be formed from an alkaloi extract of Chelidonium majus L.. The chelilutin deriv. may be a chelilutin thiophosphoric acid amide salt where the thiophosphoric acid is selected from thiophosphoric acid triaziridide, thiophosphoric acid-tri(N- sanguinarinol)ethylamine, thiophosphoric acid-di (ethyleneimido) -N-herberinol-ethylamide and N,N',N''-triethylene-thiophosphoramide.
PT7522682A1982-05-181982-07-12Method for diagnosing and for the therapeutic treatment of tu- mors diseases
PT75226B
(en)
Method for the diagnostic and the therapeutic treatment of tumors and/or infectious diseases of all sorts by the use of alkaloid compositions or the salts thereof